The prediction of colorectal cancer (CRC) response to palliative chemotherapy (CTH) is still
difficult. Patients at a higher risk of progression may benefit from more aggressive treatment …

Objectives The aim was to explore the prognostic significance of IL-6 and markers of
systemic inflammatory response (SIR), in particular C-reactive protein (CRP), in metastatic …

Background Prognostic assessment is crucial for optimal treatment. The aim of our study
was to investigate the potential impact of estrogen receptor-α (ER-α) and progesterone …

Prolactin (PRL) is a pleiotropic hormone associated with the progression of various cancers,
including colorectal cancer (CRC). Here we investigate whether the association of serum …

Background To evaluate the reliability and validity of serum carcinoembryonic antigen
(CEA), tissue polypeptide-specific antigen (TPS), vascular endothelial growth factor (VEGF) …

Background Biomarker studies on colorectal cancer (CRC) prognosis are limited to pre-
diagnostic or pre-operative measures. Post-treatment biomarkers are not well understood for …

The correlations of pretreatment serum concentrations of proinflammatory cytokines such as
interleukin (IL)‐1β, IL‐6, and tumor necrosis factor‐α (TNFα) with the clinicopathologic …

Appropriate patient selection for palliative chemotherapy is crucial in patients with metastatic
colorectal cancer (mCRC). We investigated the prognostic value of C-reactive protein (CRP) …

Background/Aim: New drugs for metastatic colorectal cancer (mCRC) have been recently
developed for use in later-line chemotherapy and have contributed to further prolongation of …

The role of human prolactin and its receptor, the prolactin receptor, in colorectal cancer is
largely unknown. Our study aimed to assess the prevalence of prolactin receptor expression …